These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
813 related items for PubMed ID: 15652672
21. Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice. Xue G, Yu L, Li S, Shen X. FEMS Immunol Med Microbiol; 2010 Mar; 58(2):202-10. PubMed ID: 19912341 [Abstract] [Full Text] [Related]
22. A single nasal dose of CCL20 chemokine induces dendritic cell recruitment and enhances nontypable Haemophilus influenzae-specific immune responses in the nasal mucosa. Kodama S, Abe N, Hirano T, Suzuki M. Acta Otolaryngol; 2011 Sep; 131(9):989-96. PubMed ID: 21534717 [Abstract] [Full Text] [Related]
23. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein]. Zhang Y, Lu SQ, Zhang YZ, Zhao BX, Xu JG. Zhonghua Yi Xue Za Zhi; 2004 Jan 02; 84(1):58-62. PubMed ID: 14990161 [Abstract] [Full Text] [Related]
24. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. Hirano T, Hou Y, Jiao X, Gu XX. FEMS Immunol Med Microbiol; 2003 Jan 21; 35(1):1-10. PubMed ID: 12589951 [Abstract] [Full Text] [Related]
28. Nasal-associated lymphoid tissue immunity and vaccine development. Kodama S, Suzuki M. Adv Otorhinolaryngol; 2011 Jan 21; 72():110-2. PubMed ID: 21865705 [Abstract] [Full Text] [Related]
29. Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines. Wu T, Chen J, Murphy TF, Green BA, Gu XX. Vaccine; 2005 Oct 25; 23(44):5177-85. PubMed ID: 16039021 [Abstract] [Full Text] [Related]
32. Efficacy of immunization with outer membrane proteins for induction of pulmonary clearance of nontypeable Haemophilus influenzae in a rat respiratory model. Esmaily F, Vaezzadeh F, Sharifi-Yazdi MK. Iran J Allergy Asthma Immunol; 2006 Jun 25; 5(2):57-61. PubMed ID: 17237577 [Abstract] [Full Text] [Related]
33. The C-terminal fragment of the internal 110-kilodalton passenger domain of the Hap protein of nontypeable Haemophilus influenzae is a potential vaccine candidate. Liu DF, Mason KW, Mastri M, Pazirandeh M, Cutter D, Fink DL, St Geme JW, Zhu D, Green BA. Infect Immun; 2004 Dec 25; 72(12):6961-8. PubMed ID: 15557618 [Abstract] [Full Text] [Related]
34. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant. Kodama S, Abe N, Hirano T, Suzuki M. Laryngoscope; 2006 Feb 25; 116(2):331-5. PubMed ID: 16467729 [Abstract] [Full Text] [Related]
37. Recombinant truncated E protein as a new vaccine candidate against nontypeable H. influenzae: Its expression and immunogenic evaluation. Behrouzi A, Bouzari S, Vaziri F, Fateh A, Afrough P, Vijeh Motlagh AD, Siadat SD. Microb Pathog; 2017 Sep 25; 110():431-438. PubMed ID: 28735080 [Abstract] [Full Text] [Related]
38. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6. Yang YP, Munson RS, Grass S, Chong P, Harkness RE, Gisonni L, James O, Kwok Y, Klein MH. Vaccine; 1997 Jun 25; 15(9):976-87. PubMed ID: 9261944 [Abstract] [Full Text] [Related]
39. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Kyd JM, Dunkley ML, Cripps AW. Infect Immun; 1995 Aug 25; 63(8):2931-40. PubMed ID: 7622215 [Abstract] [Full Text] [Related]